GlaxoSmithKline I+D, S.L.
Tres Cantos, Madrid, Comunidad de, Spain
Purpose
to access a first in class technology platform to identify the molecular targets of up to 10 anti-TB and anti-malaria lead compounds for the benefit of the wider Malaria and TB drug discovery communities
Division
Global Health
Date
November 2013
Region Served
GLOBAL
Committed amount
$2,292,562
Grant topic
Discovery and Translational Sciences
Duration (months)
76
Grantee location
Tres Cantos, Madrid, Comunidad de, Spain
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.